It’s Time To Focus On The Long Run With Immunovant Inc. (IMVT) stock

The price of Immunovant Inc. (NASDAQ: IMVT) closed at $21.20 in the last session, down -4.68% from day before closing price of $22.24. In other words, the price has decreased by -$1.04 from its previous closing price. On the day, 1533724 shares were traded. IMVT stock price reached its highest trading level at $22.09 during the session, while it also had its lowest trading level at $20.71.

Unlock the Hottest Top 10 Penny Stocks Today! Discover Now

Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.

Gain Access to Top 10 Penny Stocks Now!.



We take a closer look at IMVT’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 11.00 and its Current Ratio is at 11.00. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Apr 25 when Levine Mark S. sold 2,633 shares for $16.29 per share. The transaction valued at 42,892 led to the insider holds 330,691 shares of the business.

Macias William L. sold 509 shares of IMVT for $8,292 on Apr 25. The Chief Medical Officer now owns 350,151 shares after completing the transaction at $16.29 per share. On Apr 18, another insider, Barnett Eva Renee, who serves as the Chief Financial Officer of the company, sold 3,423 shares for $15.27 each. As a result, the insider received 52,269 and left with 352,588 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IMVT now has a Market Capitalization of 3.09B and an Enterprise Value of 2.66B.

Stock Price History:

Over the past 52 weeks, IMVT has reached a high of $24.18, while it has fallen to a 52-week low of $3.14. The 50-Day Moving Average of the stock is 16.95, while the 200-Day Moving Average is calculated to be 13.57.

Shares Statistics:

According to the various share statistics, IMVT traded on average about 958.39K shares per day over the past 3-months and 1.35M shares per day over the past 10 days. A total of 128.57M shares are outstanding, with a floating share count of 53.32M. Insiders hold about 59.50% of the company’s shares, while institutions hold 33.30% stake in the company. Shares short for IMVT as of May 14, 2023 were 4.31M with a Short Ratio of 4.53M, compared to 4.7M on Apr 13, 2023. Therefore, it implies a Short% of Shares Outstanding of 3.30% and a Short% of Float of 7.69%.

Earnings Estimates

The company has 12 analysts who recommend its stock at the moment. On average, analysts expect EPS of -$0.45 for the current quarter, with a high estimate of -$0.33 and a low estimate of -$0.51, while EPS last year was -$0.35. The consensus estimate for the next quarter is -$0.45, with high estimates of -$0.34 and low estimates of -$0.52.

Analysts are recommending an EPS of between -$0.16 and -$2.2 for the fiscal current year, implying an average EPS of -$1.68. EPS for the following year is -$1.9, with 12 analysts recommending between -$0.89 and -$2.42.